Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Price Crosses Above Two Hundred Day Moving Average – Here’s What Happened

Chronological Source Flow
Back

AI Fusion Summary

Lexicon Pharmaceuticals shares crossed their 200‑day moving average, trading up to $1.6650 with 1.3 million shares traded. Analysts shifted views: Weiss downgraded to sell, Citigroup upgraded to buy ($2.30 target), HC Wainwright set $6.00 target.
#Lexicon Pharmaceuticals #stock price #200‑day moving average #analyst ratings #Citigroup #Weiss #HC Wainwright #price target
18/03 08:47 defenseworld.net
3 Πηγές

Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Price Crosses Above Two Hundred Day Moving Average – Here’s What Happened

Lexicon Pharmaceuticalsstock price200‑day moving averageanalyst ratingsCitigroupWeiss
18/03 09:17 defenseworld.net

G. Willi-Food International (NASDAQ:WILC) Stock Crosses Above Two Hundred Day Moving Average – Time to Sell?

COMPANIESPOLITICSPRICE ARTICLES
18/03 10:17 defenseworld.net

LGI Homes (NASDAQ:LGIH) Stock Crosses Below Two Hundred Day Moving Average – Time to Sell?

PRICE ARTICLESCOMPANIESPOLITICS
Comments
Loading...
0